Concepedia

John P. Vaillancourt

JP

Statistics

Publications

25

Citations

9.9K

H-Index

20

Active since

1995

Affiliations

Merck Canada Inc. (Canada)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of British Columbia

Washington University in St. Louis

McGill University

John P. Vaillancourt is an author at Merck Canada Inc. (Canada) specializing in life sciences, apoptosis, and caspase activation.

Publications per year

1995–2012

25

Publications

25

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

Donald W. Nicholson, Ambereen Ali, Nancy A. Thornberry et al. · Nature · 1995 · 4K citations

, , +13

A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B

Nancy A. Thornberry, Thomas A. Rano, Erin P. Peterson et al. · Journal of Biological Chemistry · 1997 · 2.1K citations · Full text

, , +14

Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation

François G. Gervais, Daigen Xu, George S. Robertson et al. · Cell · 1999 · 785 citations · Full text

, , +17

The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis

J. Rotonda, Donald W. Nicholson, Kimberly M. Fazil et al. · Nature Structural Biology · 1996 · 433 citations

, , +14

Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms

Maya Saleh, John P. Vaillancourt, Rona K. Graham et al. · Nature · 2004 · 418 citations

, , +16

1–5 of 25